ReP USP - Resultado da busca

Artigo de periodico
Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas (2020)
Campanella, Nathalia C; Silva, Eduardo Caetano; Dix, Gustavo; Vazquez, Fabiana de Lima; Paula, Flavia Escremim de; Berardinelli, Gustavo N; Balancin, Marcelo; Chammas, Roger ; Lopez, Rossana Mendoza Lopez; Capelozzi, Vera Luiza
Source: Pathobiology. Unidade: FM
Subjects: ASBESTO, MUTAÇÃO, ONCOGENES, GENES SUPRESSORES DE TUMOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPANELLA, Nathalia C et al. Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas. Pathobiology, v. 87, n. 3, p. 208-215, 2020Tradução . . Disponível em: https://doi.org/10.1159/000507373. Acesso em: 18 nov. 2024.
APA
Campanella, N. C., Silva, E. C., Dix, G., Vazquez, F. de L., Paula, F. E. de, Berardinelli, G. N., et al. (2020). Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas. Pathobiology, 87( 3), 208-215. doi:10.1159/000507373
NLM
Campanella NC, Silva EC, Dix G, Vazquez F de L, Paula FE de, Berardinelli GN, Balancin M, Chammas R, Lopez RML, Capelozzi VL. Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas [Internet]. Pathobiology. 2020 ; 87( 3): 208-215.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1159/000507373
Vancouver
Campanella NC, Silva EC, Dix G, Vazquez F de L, Paula FE de, Berardinelli GN, Balancin M, Chammas R, Lopez RML, Capelozzi VL. Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas [Internet]. Pathobiology. 2020 ; 87( 3): 208-215.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1159/000507373
Artigo de periodico
Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer (2019)
Machado-rugolo, Juliana; Fabro, Alexandre Todorovic ; Ascheri, Daniel; Farhat, Cecilia; Ab'saber, Alexandre Muxfeldt; Sa, Vanessa Karen de; Nagai, Maria Aparecida; Takagaki, Teresa; Terra, Ricardo; Parra, Edwin Roger; Capelozzi, Vera Luiza
Source: Human pathology. Unidades: FM, FMRP
Subjects: NEOPLASIAS CEREBRAIS, METÁSTASE NEOPLÁSICA, NEOPLASIAS PULMONARES, IMUNOHISTOQUÍMICA, SEQUENCIAMENTO GENÉTICO, ONCOGENES, GENES SUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-RUGOLO, Juliana et al. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, v. 83, p. 177-191, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.humpath.2018.08.026. Acesso em: 18 nov. 2024.
APA
Machado-rugolo, J., Fabro, A. T., Ascheri, D., Farhat, C., Ab'saber, A. M., Sa, V. K. de, et al. (2019). Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer. Human pathology, 83, 177-191. doi:10.1016/j.humpath.2018.08.026
NLM
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
Vancouver
Machado-rugolo J, Fabro AT, Ascheri D, Farhat C, Ab'saber AM, Sa VK de, Nagai MA, Takagaki T, Terra R, Parra ER, Capelozzi VL. Usefulness of complementary next-generation sequencing and quantitative immunohistochemistry panels for predicting brain metastases and selecting treatment outcomes of non-small cell lung cancer [Internet]. Human pathology. 2019 ; 83 177-191.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.humpath.2018.08.026
Trabalho de evento-resumo periodico
Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients (2017)
Machado, Juliana; Nagai, Maria Aparecida; Fabro, Alexandre Todorovic; Capelozzi, Vera Luiza
Source: Journal of thoracic oncology. Conference titles: World conference on lun cancer - ASLC. Unidades: FM, FMRP
Subjects: NEOPLASIAS PULMONARES, ADENOCARCINOMA, PULMÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Juliana et al. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S. Acesso em: 18 nov. 2024. , 2017
APA
Machado, J., Nagai, M. A., Fabro, A. T., & Capelozzi, V. L. (2017). Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients. Journal of thoracic oncology. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
NLM
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 nov. 18 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Vancouver
Machado J, Nagai MA, Fabro AT, Capelozzi VL. Clinical relevant oncogenic drivers in advanced adenocarcinoma discloses new therapeutic target in negative EGFR/ALK/KRAS patients [Internet]. Journal of thoracic oncology. 2017 ; 12( 1): S955.[citado 2024 nov. 18 ] Available from: https://www.sciencedirect.com/journal/journal-of-thoracic-oncology/vol/12/issue/1/suppl/S
Trabalho de evento-resumo periodico
Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients (2014)
Morais, J.; Martin, P.; Velosa, A. P. P.; Andrade, P. C.; Cruz, I. B.; Miracca, E. C.; Barrence, F. A. C.; Carrasco, S.; Goldeinstein-Schainberg, C.; Nagai, M. A.; Parra, E. R.; Capelozzi, V. L.; Teodoro, W. R.
Source: Clinical and Experimental Rheumatology. Conference titles: Systemic Sclerosis World Congress. Unidades: FM, ICB
Subjects: IMUNOLOGIA, EXPRESÃO GÊNICA, COLÁGENO, SISTÊMICO ESCLERODERMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, J. et al. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.clinexprheumatol.org/article.asp?a=8201. Acesso em: 18 nov. 2024. , 2014
APA
Morais, J., Martin, P., Velosa, A. P. P., Andrade, P. C., Cruz, I. B., Miracca, E. C., et al. (2014). Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients. Clinical and Experimental Rheumatology. Pisa: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.clinexprheumatol.org/article.asp?a=8201
NLM
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 nov. 18 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Vancouver
Morais J, Martin P, Velosa APP, Andrade PC, Cruz IB, Miracca EC, Barrence FAC, Carrasco S, Goldeinstein-Schainberg C, Nagai MA, Parra ER, Capelozzi VL, Teodoro WR. Influence of alpha 2 do collagen V overexpression in physiophatology of fibrosis systemic sclerosis patients [Internet]. Clinical and Experimental Rheumatology. 2014 ; 32( 81): S-66-S67.[citado 2024 nov. 18 ] Available from: http://www.clinexprheumatol.org/article.asp?a=8201
Artigo de periodico
Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis (2012)
Martin, Patricia; Teodoro, Walcy R.; Velosa, Ana Paula P.; Morais, Jymenez de; Carrasco, Solange; Christmann, Romy B.; Goldenstein-Schainberg, Cláudia; Parra, Edwin R; Katayama, Maria Lúcia; Sotto, Mirian N.; Capelozzi, Vera L.; Yoshinari, Natalino H.
Source: Autoimmunity reviews. Unidade: FM
Subjects: MORFOMETRIA, COLÁGENO (ANORMALIDADES;MORFOLOGIA), BIÓPSIA, DOENÇAS DO COLÁGENO, PELE, SISTÊMICO ESCLERODERMA, REAÇÃO EM CADEIA POR POLIMERASE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTIN, Patricia et al. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis. Autoimmunity reviews, v. 11, n. 11, p. 827-835, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.autrev.2012.02.017. Acesso em: 18 nov. 2024.
APA
Martin, P., Teodoro, W. R., Velosa, A. P. P., Morais, J. de, Carrasco, S., Christmann, R. B., et al. (2012). Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis. Autoimmunity reviews, 11( 11), 827-835. doi:10.1016/j.autrev.2012.02.017
NLM
Martin P, Teodoro WR, Velosa APP, Morais J de, Carrasco S, Christmann RB, Goldenstein-Schainberg C, Parra ER, Katayama ML, Sotto MN, Capelozzi VL, Yoshinari NH. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis [Internet]. Autoimmunity reviews. 2012 ; 11( 11): 827-835.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.autrev.2012.02.017
Vancouver
Martin P, Teodoro WR, Velosa APP, Morais J de, Carrasco S, Christmann RB, Goldenstein-Schainberg C, Parra ER, Katayama ML, Sotto MN, Capelozzi VL, Yoshinari NH. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis [Internet]. Autoimmunity reviews. 2012 ; 11( 11): 827-835.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.autrev.2012.02.017
Artigo de periodico
Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis (2010)
Parra, E. R.; Teodoro, W. R.; Morais, J. de; Katayama, M. L. H.; Souza, R. de; Yoshinari, N. H.; Capelozzi, V. L.
Source: European journal of clinical investigation. Unidade: FM
Subjects: BIOLOGIA MOLECULAR, RNA, COLÁGENO, SISTÊMICO ESCLERODERMA, FIBROSE PULMONAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARRA, E. R. et al. Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis. European journal of clinical investigation, v. 40, n. 2, p. 110-120, 2010Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2362.2009.02224.x. Acesso em: 18 nov. 2024.
APA
Parra, E. R., Teodoro, W. R., Morais, J. de, Katayama, M. L. H., Souza, R. de, Yoshinari, N. H., & Capelozzi, V. L. (2010). Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis. European journal of clinical investigation, 40( 2), 110-120. doi:10.1111/j.1365-2362.2009.02224.x
NLM
Parra ER, Teodoro WR, Morais J de, Katayama MLH, Souza R de, Yoshinari NH, Capelozzi VL. Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis [Internet]. European journal of clinical investigation. 2010 ; 40( 2): 110-120.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/j.1365-2362.2009.02224.x
Vancouver
Parra ER, Teodoro WR, Morais J de, Katayama MLH, Souza R de, Yoshinari NH, Capelozzi VL. Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis [Internet]. European journal of clinical investigation. 2010 ; 40( 2): 110-120.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1111/j.1365-2362.2009.02224.x
Artigo de periodico
Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis: a cross-sectional study (2010)
Velosa, Ana Paula P.; Teodoro, Walcy R.; Anjos, Daniel M. dos; Konno, Renata; Oliveira, Cristiane C.; Katayama, Maria L. H.; Parra, Edwin R.; Capelozzi, Vera L.; Yoshinari, Natalino H.
Source: Respiratory Research. Unidade: FM
Subjects: COLÁGENO, RNA MENSAGEIRO, SISTÊMICO ESCLERODERMA, TOLERÂNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VELOSA, Ana Paula P. et al. Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis: a cross-sectional study. Respiratory Research, v. 11, n. 1, p. 1-10, 2010Tradução . . Disponível em: http://respiratory-research.com/content/pdf/1465-9921-11-1.pdf. Acesso em: 18 nov. 2024.
APA
Velosa, A. P. P., Teodoro, W. R., Anjos, D. M. dos, Konno, R., Oliveira, C. C., Katayama, M. L. H., et al. (2010). Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis: a cross-sectional study. Respiratory Research, 11( 1), 1-10. Recuperado de http://respiratory-research.com/content/pdf/1465-9921-11-1.pdf
NLM
Velosa APP, Teodoro WR, Anjos DM dos, Konno R, Oliveira CC, Katayama MLH, Parra ER, Capelozzi VL, Yoshinari NH. Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis: a cross-sectional study [Internet]. Respiratory Research. 2010 ; 11( 1): 1-10.[citado 2024 nov. 18 ] Available from: http://respiratory-research.com/content/pdf/1465-9921-11-1.pdf
Vancouver
Velosa APP, Teodoro WR, Anjos DM dos, Konno R, Oliveira CC, Katayama MLH, Parra ER, Capelozzi VL, Yoshinari NH. Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis: a cross-sectional study [Internet]. Respiratory Research. 2010 ; 11( 1): 1-10.[citado 2024 nov. 18 ] Available from: http://respiratory-research.com/content/pdf/1465-9921-11-1.pdf
Artigo de periodico
Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature (2010)
Ferrarotto, Renata; Schetino, Guilherme; Freitas, Daniela; Capelozzi, Vera; Hoff, Paulo M.
Source: Oncology Reviews. Unidade: FM
Subjects: DOENÇAS PULMONARES INTERSTICIAIS, DOENÇA CRÔNICA, NEOPLASIA ENDÓCRINA MÚLTIPLA, ESTADIAMENTO DE NEOPLASIAS, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERRAROTTO, Renata et al. Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature. Oncology Reviews, v. 4, n. 1, p. 101-106, 2010Tradução . . Disponível em: https://doi.org/10.4081/53. Acesso em: 18 nov. 2024.
APA
Ferrarotto, R., Schetino, G., Freitas, D., Capelozzi, V., & Hoff, P. M. (2010). Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature. Oncology Reviews, 4( 1), 101-106. doi:10.4081/53
NLM
Ferrarotto R, Schetino G, Freitas D, Capelozzi V, Hoff PM. Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature [Internet]. Oncology Reviews. 2010 ; 4( 1): 101-106.[citado 2024 nov. 18 ] Available from: https://doi.org/10.4081/53
Vancouver
Ferrarotto R, Schetino G, Freitas D, Capelozzi V, Hoff PM. Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature [Internet]. Oncology Reviews. 2010 ; 4( 1): 101-106.[citado 2024 nov. 18 ] Available from: https://doi.org/10.4081/53

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies